Nutraceuticals with a clinically detectable blood pressure-lowering effect: a review of available randomized clinical trials and their meta-analyses

British Journal of Clinical Pharmacology

Volumn 83, Issue 1, 2017, Pages 163-171

  Borghi, Claudio ^a   Cicero, Arrigo F G ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

blood pressure; BP; clinical evidence review; dietary supplements; hypertension; nutraceuticals

Indexed keywords

AMINO ACID; ANTIHYPERTENSIVE AGENT; ARGININE; ASCORBIC ACID; CALCIUM; FLAVONOID; GARLIC EXTRACT; GRAPE SEED EXTRACT; ISOFLAVONE DERIVATIVE; LYCOPENE; MAGNESIUM; MELATONIN; NUTRACEUTICAL; OLIVE OIL; OMEGA 3 FATTY ACID; POTASSIUM; PROBIOTIC AGENT; PROTEIN; PYCNOGENOL; RESVERATROL; UBIDECARENONE; ANTIOXIDANT;

ANTIHYPERTENSIVE ACTIVITY; BEETROOT JUICE; BLOOD PRESSURE; CACAO; DIETARY SUPPLEMENT; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; HYPERTENSION; MEDITERRANEAN DIET; META ANALYSIS; PRIORITY JOURNAL; REVIEW; DIET THERAPY; DRUG EFFECTS; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTIOXIDANTS; BLOOD PRESSURE; DIET, MEDITERRANEAN; DIETARY SUPPLEMENTS; HUMANS; HYPERTENSION; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84960971302     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12902     Document Type: Review

References (91)

1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217–23.
2. Lawes CM, Vanders HS, Rodgers A. Global burden of blood pressure related disease, 2001. Lancet 2008; 371: 1513–8.
3. McInnes GT. Lowering blood pressure for cardiovascular risk reduction. J Hypertens Suppl 2005; 23: S3–8.
4. ESH/ESC Task Force for the Management of Arterial Hypertension. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens 2013; 31: 1925–38.
5. Appel LJ; American Society of Hypertension Writing Group. ASH position paper: dietary approaches to lower blood pressure. J Am Soc Hypertens 2009; 3: 321–31.
6. McCartney DM, Byrne DG, Turner MJ. Dietary contributors to hypertension in adults reviewed. Ir J Med Sci 2015; 84: 81–90.
7. Miller ER 3rd, Erlinger TP, Appel LJ. The effects of macronutrients on blood pressure and lipids: an overview of the DASH and OmniHeart trials. Curr Atheroscler Rep 2006; 8: 460–5.
8. Pérez-López FR, Chedraui P, Quadro JL. Effects of the Mediterranean diet on longevity and age-related morbid conditions. Maturitas 2009; 64: 67–79.
9. Houston M. The role of nutrition and nutraceutical supplements in the treatment of hypertension. World J Cardiol 2014; 6: 38–66.
10. Psaltopoulou T, Naska A, Orfanos P, Trichopoulos D, Mountokalakis T, Trichopoulou A. Olive oil, the Mediterranean diet, and arterial blood pressure: the Greek European Prospective Investigation into Cancer and Nutrition (EPIC) study. Am J Clin Nutr 2004; 80: 1012–8.
11. Toledo E, Hu FB, Estruch R, Buil-Cosiales P, Corella D, Salas-Salvadó J, Covas MI, Arós F, Gómez-Gracia E, Fiol M, Lapetra J, Serra-Majem L, Pinto X, Lamuela-Raventós RM, Saez G, Bulló M, Ruiz-Gutiérrez V, Ros E, Sorli JV, Martinez-Gonzalez MA. Effect of the Mediterranean diet on blood pressure in the PREDIMED trial: results from a randomized controlled trial. BMC Med 2013; 11: 207.
12. Perrinjaquet-Moccetti T, Busjahn A, Schmidlin C, Schmidt A, Bradl B, Aydogan C. Food supplementation with an olive (Olea uropaea L.) leaf extract reduces blood pressure in borderline hypertensive monozygotic twins. Phytother Res 2008; 22: 1239–42.
13. Clements WT, Lee SR, Bloomer RJ. Nitrate ingestion: a review of the health and physical performance effects. Nutrients 2014; 6: 5224–64.
14. Kapil V, Milsom AB, Okorie M, Maleki-Toyserkani S, Akram F, Rehman F, Arghandawi S, Pearl V, Benjamin N, Loukogeorgakis S, Macallister R, Hobbs AJ, Webb AJ, Ahluwalia A. Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite-derived NO. Hypertension 2010; 56: 274–81.
15. Kapil V, Khambata RS, Robertson A, Caulfield MJ, Ahluwalia A. Dietary nitrate provides sustained blood pressure lowering in hypertensive patients: a randomized, phase 2, double-blind, placebo-controlled study. Hypertension 2015; 65: 320–7.
16. Coles LT, Clifton PM. Effect of beetroot juice on lowering blood pressure in free-living, disease-free adults: a randomized, placebo-controlled trial. Nutr J 2012; 11: 106.
17. Siervo M, Lara J, Ogbonmwan I, Mathers JC. Inorganic nitrate and beetroot juice supplementation reduces blood pressure in adults: a systematic review and meta-analysis. J Nutr 2013; 143: 818–26.
18. Habauzit V, Morand C. Evidence for a protective effect of polyphenols-containing foods on cardiovascular health: an update for clinicians. Ther Adv Chronic Dis 2012; 3: 87–106.
19. Grassi D, Desideri G, Necozione S, Lippi C, Casale R, Properzi G, Blumberg JB, Ferri C. Blood pressure is reduced and insulin sensitivity increased in glucose-intolerant, hypertensive subjects after 15 days of consuming high-polyphenol dark chocolate. J Nutr 2008; 138: 1671–6.
20. Grassi D, Desideri G, Necozione S, Ruggieri F, Blumberg JB, Stornello M, Ferri C. Protective effects of flavanol-rich dark chocolate on endothelial function and wave reflection during acute hyperglycemia. Hypertension 2012; 60: 827–32.
21. Ried K, Sullivan TR, Fakler P, Frank OR, Stocks NP. Effect of cocoa on blood pressure. Cochrane Database Syst Rev 2012; 8: CD008893.
22. Anon. Largest research trial of cocoa flavanols and heart health to be launched [online]. Available at https://clinicaltrials.gov/ct2/show/NCT02422745 (last acceced 24 February 2016).
23. Liu G, Mi XN, Zheng XX, Xu YL, Lu J, Huang XH. Effects of tea intake on blood pressure: a meta-analysis of randomised controlled trials. Br J Nutr 2014; 112: 1043–54.
24. Ihm SH, Jang SW, Kim OR, Chang K, Oak MH, Lee JO, Chang K, Oak MH, Lee JO, Lim DY, Kim JH. Decaffeinated green tea extract improves hypertension and insulin resistance in a rat model of metabolic syndrome. Atherosclerosis 2012; 224: 377–83.
25. Wahabi HA, Alansary LA, Al-Sabban AH, Glasziuo P. The effectiveness of Hibiscus sabdariffa in the treatment of hypertension: a systematic review. Phytomedicine 2010; 17: 83–6.
26. Cicero AF, Ertek S, Borghi C. Omega-3 polyunsaturated fatty acids: their potential role in blood pressure prevention and management. Curr Vasc Pharmacol 2009; 7: 330–7.
27. Miller PE, Van Elswyk M, Alexander DD. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials. Am J Hypertens 2014; 27: 885–96.
28. Pase MP, Grima NA, Sarris J. Do long-chain n-3 fatty acids reduce arterial stiffness? A meta-analysis of randomised controlled trials. Br J Nutr 2011; 106: 974–80.
29. Rebholz CM, Friedman EE, Powers LJ, Arroyave WD, He J, Kelly TN. Dietary protein intake and blood pressure: a meta-analysis of randomized controlled trials. Am J Epidemiol 2012; 176 (S7): S27–43.
30. Liu XX, Li SH, Chen JZ, Sun K, Wang XJ, Wang XG, Hui RT. Effect of soy isoflavones on blood pressure: a meta-analysis of randomized controlled trials. Nutr Metab Cardiovasc Dis 2012; 22: 463–70.
31. Dong JY, Szeto IM, Makinen K, Gao Q, Wang J, Qin LQ, Zhao Y. Effect of probiotic fermented milk on blood pressure: a meta-analysis of randomised controlled trials. Br J Nutr 2013; 110: 1188–94.
32. Siltari A, Viitanen R, Kukkurainen S, Vapaatalo H, Valjakka J. Does the cis/trans configuration of peptide bonds in bioactive tripeptides play a role in ACE-1 enzyme inhibition? Biologics 2014; 8: 59–65.
33. Cicero AF, Gerocarni B, Laghi L, Borghi C. Blood pressure lowering effect of lactotripeptides assumed as functional foods: a meta-analysis of current available clinical trials. J Hum Hypertens 2011; 25: 425–36.
34. Cicero AF, Aubin F, Azais-Braesco V, Borghi C. Do the lactotripeptides isoleucine-proline-proline and valine-proline-proline reduce systolic blood pressure in European subjects? A meta-analysis of randomized controlled trials. Am J Hypertens 2013; 26: 442–9.
35. Cicero AF, Rosticci M, Gerocarni B, Bacchelli S, Veronesi M, Strocchi E, Borghi C. Lactotripeptides effect on office and 24-h ambulatory blood pressure, blood pressure stress response, pulse wave velocity and cardiac output in patients with high-normal blood pressure or first-degree hypertension: a randomized double-blind clinical trial. Hypertens Res 2011; 34: 1035–40.
36. Lordan S, Ross P, Stanton C. Marine bioactives as functional food ingredients: potential to reduce the incidence of chronic disease. Mar Drugs 2011; 9: 1056–100.
37. Rajapakse NW, Mattson DL. Role of L-arginine in nitric oxide production in health and hypertension. Clin Exp Pharmacol Physiol 2009; 36: 249–55.
38. Dong JY, Qin JQ, Zhang ZL, Zhao Y, Wang J, Arigoni F, Zhang W. Effect of oral L-arginine supplementation on blood pressure: a meta-analysis of randomized, double-blind, placebo-controlled trials. Am Heart J 2011; 162: 959–65.
39. Perez V, Chang ET. Sodium-to-potassium ratio and blood pressure, hypertension, and related factors. Adv Nutr 2014; 5: 712–41.
40. Whelton PK, He J. Potassium in preventing and treating high blood pressure. Semin Nephrol 1999; 19: 494–9.
41. Gu D, He J, Xigui W, Duan X, Whelton PK. Effect of potassium supplementation on blood pressure in Chinese: a randomized, placebo controlled trial. J Hypertens 2001; 19: 1325–31.
42. D'Elia L, Barba G, Cappuccio FP, Strazzullo P. Potassium intake, stroke, and cardiovascular disease a meta-analysis of prospective studies. J Am Coll Cardiol 2011; 57: 1210–9.
43. Yang Q, Liu T, Kuklina EV, Flanders WD, Hong Y, Gillespie C, Chang MH, Gwinn M, Dowling N, Khoury MJ, Hu FB. Sodium and potassium intake and mortality among US adults: prospective data from the third national health and nutrition examination survey. Arch Intern Med 2011; 171: 1183–91.
44. Houston MC. The importance of potassium in managing hypertension. Curr Hypertens Rep 2011; 13: 309–17.
45. Houston MC, Harper KJ. Potassium, magnesium, and calcium: their role in both the cause and treatment of hypertension. J Clin Hypertens 2008; 10 (7 S2): 3–11.
46. Kass L, Weekes J, Carpenter L. Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr 2012; 66: 411–8.
47. Laurant P, Touyz RM. Physiological and pathophysiological role of magnesium in the cardiovascular system: implications in hypertension. J Hypertens 2000; 18: 1177–91.
48. Widman L, Wester PO, Stegmayr BG, Wirell MP. The dose dependent reduction in blood pressure through administration of magnesium: a double-blind placebo-controlled cross-over trial. Am J Hypertens 1993; 6: 41–5.
49. Houston MC. The role of magnesium in hypertension and cardiovascular disease. J Clin Hyperten 2011; 13: 843–7.
50. Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 2010; 8: CD001059.
51. McCartney DM, Byrne DG, Turner MJ. Dietary contributors to hypertension in adults reviewed. Ir J Med Sci 2015; 184: 81–90.
52. Ness AR, Khaw K-T, Bingham S, Day NE. Vitamin C status and blood pressure. J Hypertens 1996; 14: 503–8.
53. Enstrom JE, Kanim LE, Klein M. Vitamin C intake and mortality among a sample of the United States population. Epidemiology 1992; 3: 194–202.
54. Block G, Jensen CD, Norkus EP, Hudes M, Crawford PB. Vitamin C in plasma is inversely related to blood pressure and change in blood pressure during the previous year in young black and white women. Nutr J 2008; 17: 35–46.
55. Ness AR, Chee D, Elliott P. Vitamin C and blood pressure – an overview. J Hum Hypertens 1997; 11: 343–50.
56. Block G, Mangels AR, Norkus EP, Patterson BH, Levander OA, Taylor PR. Ascorbic acid status and subsequent diastolic and systolic blood pressure. Hypertension 2001; 37: 261–7.
57. Sherman DL, Keaney JF, Biegelsen ES, Duffy SJ, Coffman JD, Vita JA. Pharmacological concentrations of ascorbic acid are required for the beneficial effect on endothelial vasomotor function in hypertension. Hypertension 2000; 35: 936–41.
58. Juraschek SP, Guallar E, Appel LJ, Miller ER 3rd. Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2012; 95: 1079–88.
59. Mahajan AS, Babbar R, Kansai N, Agarwal SK, Ray PC. Antihypertensive and antioxidant action of amlodipine and vitamin C in patients of essential hypertension. J Clin Biochem Nutr 2007; 402: 141–7.
60. Sato K, Dohi Y, Kojima M, Miyagawa K. Effects of ascorbic acid on ambulatory blood pressure in elderly patients with refractory hypertension. Arzneimittelforschung 2006; 6: 535–40.
61. Plantinga Y, Ghiadoni L, Magagna A, Biannarelli C. Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. Am J Hypertens 2007; 20: 392–7.
62. Simon JA. Vitamin C and cardiovascular disease: a review. J Am Coll Nutr 1992; 11: 107–25.
63. Hatzitolios A, Iliadis F, Katsiki N, Baltatzi M. Is the antihypertensive effect of dietary supplements via aldehydes reduction evidence based: a systemic review. Clin Exp Hypertens 2008; 30: 628–39.
64. Ledlerc PC, Proulx CD, Arquin G, Belanger S. Ascorbic acid decreases the binding affinity of the AT1 receptor for angiotensin II. Am J Hypertens 2008; 21: 67–71.
65. Cicero AF, Derosa G, Manca M, Bove M, Borghi C, Gaddi AV. Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: a six-month, randomized clinical trial. Clin Exp Hypertens 2007; 29: 383–94.
66. Pal S, Khoussousi A, Binns C, Dhaliwal S, Radavelli-Bagatini S. The effects of 12-week psyllium fibre supplementation or healthy diet on blood pressure and arterial stiffness in overweight and obese individuals. Br J Nutr 2012; 107: 725–34.
67. Houston MC. Nutrition and nutraceuticals supplements in the treatment of hypertension. Prog Cardiovasc Dis 2005; 47: 396–449.
68. Caligiuri SP, Edel AL, Aliani M, Pierce GN. Flaxseed for hypertension: implications for blood pressure regulation. Curr Hypertens Rep 2014; 16: 499.
69. Li H, Xia N, Förstermann U. Cardiovascular effects and molecular targets of resveratrol. Nitric Oxide 2012; 26: 102–10.
70. Liu Y, Ma W, Zhang P, He S, Huang D. Effect of resveratrol on blood pressure: a meta-analysis of randomized controlled trials. Clin Nutr 2015; 4: 27–34.
71. Feringa HH, Laskey DA, Dickson JE, Coleman CI. The effect of grape seed extract on cardiovascular risk markers: a meta-analysis of randomized controlled trials. J Am Diet Assoc 2011; 111: 1173–81.
72. Langsjoen PH, Langsjoen AM. Overview of the use of CoQ10 in cardiovascular disease. Biofactors 1999; 9: 273–84.
73. Ho MJ, Bellusci A, Wright JM. Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension. Cochrane Database Syst Rev 2009; 4: CD007435.
74. Ankola DD, Viswanas B, Bhardqaj V, Ramarao P, Kumar MN. Development of potent oral nanoparticulate formulation of coenzyme Q10 for treatment of hypertension: can the simple nutritional supplement be used as first line therapeutic agents for prophylaxis/therapy? Eur J Pharm Biopharm 2007; 67: 361–9.
75. Ried K, Fakler P. Protective effect of lycopene on serum cholesterol and blood pressure: meta-analyses of intervention trials. Maturitas 2011; 68: 299–310.
76. Paran E, Novac C, Engelhard YN, Hazan-Halevy I. The effects of natural antioxidants form tomato extract in treated but uncontrolled hypertensive patients. Cardiovasc Drugs Ther 2009; 23: 145–51.
77. Burton-Freeman B, Sesso HD. Whole food versus supplement: comparing the clinical evidence of tomato intake and lycopene supplementation on cardiovascular risk factors. Adv Nutr 2014; 5: 457–85.
78. Maimoona A, Naeem I, Saddiqe Z, Jameel K. A review on biological, nutraceutical and clinical aspects of French maritime pine bark extract. J Ethnopharmacol 2011; 133: 261–77.
79. Zibadi S, Rohdewald PJ, Park D, Watson RR. Reduction of cardiovascular risk factors in subjects with type 2 diabetes by pycnogenol supplementation. Nutr Res 2008; 28: 315–20.
80. Liu X, Wei J, Tan F, Zhou S, Würthwein G, Rohdewald P. Pycnogenol, French maritime pine bark extract, improves endothelial function of hypertensive patients. Life Sci 2004; 74: 855–62.
81. Rodella LF, Favero G, Foglio E, Rossini C, Castrezzati S, Lonati C, Rezzani R. Vascular endothelial cells and dysfunctions: role of melatonin. Front Biosci 2013; 5: 119–29.
82. Grossman E, Laudon M, Zisapel N. Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials. Vasc Health Risk Manag 2011; 7: 577–84.
83. Scheer FA, Morris CJ, Garcia JI, Smales C, Kelly EE, Marks J, Malhotra A, Shea SA. Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: a randomized controlled trial. Sleep 2012; 35: 1395–402.
84. Zaslavskaya RM, Lilitsa GV, Dilmagambetova GS, Halberg F, Cornélissen G, Otsuka K, Singh RB, Stoynev A, Ikonomov O, Tarquini R, Perfetto F, Schwartzkopff O, Bakken EE. Melatonin, refractory hypertension, myocardial ischemia and other challenges in nightly blood pressure lowering. Biomed Pharmacother 2004; 58 (S1): S129–34.
85. Ried K, Fakler P. Potential of garlic (Allium sativum) in lowering high blood pressure: mechanisms of action and clinical relevance. Integr Blood Press Control 2014; 7: 71–82.
86. Butt MS, Sultan MT, Butt MS, Iqbal J. Garlic: nature's protection against physiological threats. Crit Rev Food Sci Nutr 2009; 49: 538–51.
87. Rohner A, Ried K, Sobenin IA, Bucher HC, Nordmann AJ. A systematic review and metaanalysis on the effects of garlic preparations on blood pressure in individuals with hypertension. Am J Hypertens 2015; 28: 414–23.
88. Reid K, Frank OR, Stocks NP. Aged garlic extract lowers blood pressure in patients with treated but uncontrolled hypertension: a randomized controlled trial. Maturitas 2010; 67: 144–50.
89. Khalesi S, Sun J, Buys N, Jayasinghe R. Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials. Hypertension 2014; 64: 897–903.
90. Dong JY, Szeto IM, Makinen K, Gao Q, Wang J, Qin LQ, Zhao Y. Effect of probiotic fermented milk on blood pressure: a meta-analysis of randomised controlled trials. Br J Nutr 2013; 110: 1188–94.
91. Sirtori CR, Arnoldi A, Cicero AF. Nutraceuticals for blood pressure control. Ann Med 2015; 47: 447–56.